Shares in Baxter (NYSE:BAX) rose today in pre-market activity after the medical device maker beat expectations on Wall Street with its first-quarter results.
The Deerfield, Ill.-based company posted profits of $389 million, or 71¢ per share, on sales of $2.68 billion for the 3 months ended March 31, for bottom-line growth of 43% on sales growth of 8.2% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Baxter beats The Street with Q1 results appeared first on MassDevice.
from MassDevice https://ift.tt/2Hu9KkL
Cap comentari:
Publica un comentari a l'entrada